Figure 1From: Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 Biomarker modeling in training (Sample Set B) and validation (Sample Set A) sets. Biomarker models were generated for all two and three marker combinations in Sample Set B (Table 3). These models were then validated in PDAC versus healthy/non-cancer group of Sample Set A (Table 4). Displayed are three models which showed a significant improvement in AUC to that of CA19.9 alone in both training (1a) and validation sets (1b). Confidence intervals (CI) for AUC were calculated using DeLong’s method. P-values are given in Table 4.Back to article page